Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amexdrug Corporation

Market Cap 19.45M 16.99M 15.72M 14.67M 27.54M 1.84B 27.74M 187M 72.68M 904M 73.01M 71.43M 3.14B P/E 2011
168x
P/E 2012 103x
Enterprise Value 20.23M 17.67M 16.35M 15.26M 28.64M 1.91B 28.85M 194M 75.58M 940M 75.94M 74.29M 3.26B EV / Sales 2011
1.38x
EV / Sales 2012 1.01x
Free-Float
8.4%
Yield 2011 *
-
Yield 2012 -
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.41
10 years 0
Extreme 0.0001
1.12
Manager TitleAgeSince
Chief Executive Officer 66 01/04/2000
General Counsel - -
Director TitleAgeSince
Chairman 66 01/04/2000
Director/Board Member 76 01/12/2001
Director/Board Member 72 01/12/2001
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+100.00%-80.00% 33.82K
+3.03%-2.47%+6.12%+84.24% 87.21B
+1.50%-0.93%+37.57%+145.97% 52.17B
-0.72%-2.14%-12.74%+222.35% 22.25B
+1.13%-0.86%-7.61%-21.99% 7.96B
+0.49%-0.28%-30.28%-31.45% 7.45B
+0.45%-7.91%-15.46%-35.04% 6.49B
+3.36%+2.23%+18.33%+21.67% 6.17B
+0.42%+0.06%-2.48%+18.07% 5.19B
+0.84%-0.82%-3.98%-12.77% 3.53B
Average +1.01%-1.14%+8.95%+31.11% 19.84B
Weighted average by Cap. +1.85%-2.68%+9.63%+98.05%

Financials

2011 2012
Net sales 12.41M 10.84M 10.03M 9.36M 17.57M 1.17B 17.7M 119M 46.36M 576M 46.58M 45.57M 2B 9.15M 7.99M 7.39M 6.9M 12.96M 865M 13.05M 87.87M 34.19M 425M 34.35M 33.6M 1.48B
Net income 101K 87.95K 81.35K 75.93K 143K 9.51M 144K 967K 376K 4.68M 378K 370K 16.25M 82.03K 71.68K 66.3K 61.89K 116K 7.75M 117K 788K 307K 3.81M 308K 301K 13.24M
Net Debt 150K 131K 121K 113K 212K 14.18M 214K 1.44M 561K 6.97M 563K 551K 24.21M 778K 680K 629K 587K 1.1M 73.51M 1.11M 7.47M 2.91M 36.14M 2.92M 2.86M 126M
Logo Amexdrug Corporation
Amexdrug Corporation is a vertically integrated company, which is focused on healthcare and operating in the highly lucrative pharmaceutical, medical and cosmeceutical industry. The Company has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.
Employees
11
  1. Stock Market
  2. Stocks
  3. AXRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!